Nalaganje...
Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials
The management of chronic lymphocytic leukemia (CLL) has undergone dramatic changes over the previous 2 decades with the introduction of multiple new therapies and new combinations. Management of the newly diagnosed asymptomatic patient has not significantly changed outside of the development of a n...
Shranjeno v:
| izdano v: | Hematology Am Soc Hematol Educ Program |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6913497/ https://ncbi.nlm.nih.gov/pubmed/31808904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019001321 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|